Delivery Order SPE2DB22D2214-SPE2DB24FS4WM
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a medical product, with a ceiling value of $1,464.99 and a completion date of May 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML. The contract has a ceiling value of $7,680.13 and a period of performance through March 13, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML medical products. The firm-fixed-price contract has a ceiling value of $11,517.13 and a completion date of November 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The contract has a firm fixed-price pricing type, a ceiling value of $7,467.52, and a period of performance through May 30, 2025. The contract is not set-aside and was awarded on May 29, 2025. AmerisourceBergen Drug Corp, a for-profit...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML, a specialty pharmaceutical product, to support military treatment programs and facilities. The delivery order has a ceiling value of $2,473.13 and a period of performance through March 18, 2024. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML pharmaceuticals. The contract has a potential value of $5,026.04 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This delivery order contract is part of a larger indefinite...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML. The contract has a ceiling value of $5,833.20 and is a firm fixed price delivery order running through March 7, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The contract has a ceiling value of $1,382.31 and runs through September 9, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML, a specialty pharmaceutical product, with a ceiling value of $2,599.92 and a period of performance through March 25, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,330.33, is for the delivery of OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML, a medical product, with a completion date of April 1, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS4WMDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML, a prescription medication. The contract has a ceiling value of $2,153.78 and a completion date of May 15, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 5/14/24 |